Skip to main content
Erschienen in: Neuroradiology 8/2006

01.08.2006 | Diagnostic Neuroradiology

Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs

verfasst von: R. Agid, R. I. Farb, R. A. Willinsky, D. J. Mikulis, G. Tomlinson

Erschienen in: Neuroradiology | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the accuracy of previously reported neuroimaging signs in establishing or excluding the diagnosis of idiopathic intracranial hypertension (IIH). In a retrospective study, 30 patients with confirmed IIH and 56 controls were evaluated with brain magnetic resonance imaging. All examinations were evaluated in a blinded fashion by three neuroradiologists for the presence or absence of the ‘traditional’ signs of IIH: empty sella turcica, deformation of the pituitary, slit-like ventricles, ‘tight’ subarachnoid spaces, flattening of the posterior globe, protrusion of the optic nerve, enhancement of the optic nerve head, distension of the optic nerve sheath and vertical tortuosity of the optic nerve. Optic nerve protrusion and enhancement, slit-like ventricles and tight cerebrospinal fluid spaces were not significantly associated with IIH (P>0.05). Posterior globe flattening, optic nerve sheath distension, optic nerve tortuosity, pituitary deformity and empty sella turcica were significantly associated with IIH (P<0.05). However, most of these are not helpful in a clinical setting, with the exception of posterior globe flattening. This is the only sign that, if present, strongly suggests the diagnosis of IIH (specificity 100%, 95% CI 93.6% to 100%; sensitivity 43.5%, 95% CI 27.3% to 60.8%; positive likelihood ratio 49.7). The majority of the reported signs for IIH on cross-sectional imaging are not helpful in establishing or excluding the diagnosis of IIH, and are of no value in the clinical setting. Flattening of the posterior aspect of the globe is the only sign that, if present, is suggestive of the diagnosis of IIH.
Literatur
1.
Zurück zum Zitat Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495PubMedCrossRef Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495PubMedCrossRef
2.
Zurück zum Zitat Farb RI, Vanek I, Scott J, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMed Farb RI, Vanek I, Scott J, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424PubMed
3.
Zurück zum Zitat Weisberg LA (1985) Computed tomography in benign intracranial hypertension. Neurology 35:1075–1078PubMed Weisberg LA (1985) Computed tomography in benign intracranial hypertension. Neurology 35:1075–1078PubMed
4.
Zurück zum Zitat Gibby WA, Cohen MS, Goldberg HI, Sergott RC (1993) Pseudotumor cerebri: CT findings and correlation with vision loss. AJR Am J Roentgenol 160:143–146PubMed Gibby WA, Cohen MS, Goldberg HI, Sergott RC (1993) Pseudotumor cerebri: CT findings and correlation with vision loss. AJR Am J Roentgenol 160:143–146PubMed
5.
Zurück zum Zitat Yuh WT, Zhu M, Taoka T, Quets JP, Maley JE, Muhonen MG, Schuster ME, Kardon RH (2000) MR imaging of pituitary morphology in idiopathic intracranial hypertension. J Magn Reson Imaging 12:808–813PubMedCrossRef Yuh WT, Zhu M, Taoka T, Quets JP, Maley JE, Muhonen MG, Schuster ME, Kardon RH (2000) MR imaging of pituitary morphology in idiopathic intracranial hypertension. J Magn Reson Imaging 12:808–813PubMedCrossRef
6.
Zurück zum Zitat Gass A, Barker GJ, Riordan-Eva P, MacManus D, Sanders M, Tofts PS, McDonald WI, Moseley IF, Miller DH (1996) MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 38:769–773PubMedCrossRef Gass A, Barker GJ, Riordan-Eva P, MacManus D, Sanders M, Tofts PS, McDonald WI, Moseley IF, Miller DH (1996) MRI of the optic nerve in benign intracranial hypertension. Neuroradiology 38:769–773PubMedCrossRef
7.
Zurück zum Zitat Kesler A, Yaffe D, Shapira M, Kott E (1996) Optic nerve sheath enlargement and reversal of optic nerve head in pseudotumor cerebri (in Hebrew). Harefuah 130:457–459, 503PubMed Kesler A, Yaffe D, Shapira M, Kott E (1996) Optic nerve sheath enlargement and reversal of optic nerve head in pseudotumor cerebri (in Hebrew). Harefuah 130:457–459, 503PubMed
8.
Zurück zum Zitat Brodsky MC, Vaphiades M (1998) Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 105:1686–1693PubMedCrossRef Brodsky MC, Vaphiades M (1998) Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 105:1686–1693PubMedCrossRef
9.
Zurück zum Zitat Zagardo MT, Cail WS, Kelman SE, Rothman MI (1996) Reversible empty sella in idiopathic intracranial hypertension: an indicator of successful therapy? AJNR Am J Neuroradiol 17:1953–1956PubMed Zagardo MT, Cail WS, Kelman SE, Rothman MI (1996) Reversible empty sella in idiopathic intracranial hypertension: an indicator of successful therapy? AJNR Am J Neuroradiol 17:1953–1956PubMed
10.
Zurück zum Zitat Jaeschke R, Guyatt GH, Sackett DL (1994) Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271(9):703–707PubMedCrossRef Jaeschke R, Guyatt GH, Sackett DL (1994) Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271(9):703–707PubMedCrossRef
11.
Zurück zum Zitat Fleiss JL (1981) Statistical methods for rates and proportions. Wiley, New York Fleiss JL (1981) Statistical methods for rates and proportions. Wiley, New York
12.
Zurück zum Zitat Manfre L, Lagalla R, Mangiameli A, Lupo F, Giuffre G, Ponte F, Cardinale AE (1995) Idiopathic intracranial hypertension: orbital MRI. Neuroradiology 37(6):459–461PubMedCrossRef Manfre L, Lagalla R, Mangiameli A, Lupo F, Giuffre G, Ponte F, Cardinale AE (1995) Idiopathic intracranial hypertension: orbital MRI. Neuroradiology 37(6):459–461PubMedCrossRef
13.
Zurück zum Zitat Yuh WT, Simonson TM, Wang AM, Koci TM, Tali ET, Fisher DJ, Simon JH, Jinkins JR, Tsai F (1994) Venous sinus occlusive disease: MR findings. AJNR Am J Neuroradiol 15:309–316PubMed Yuh WT, Simonson TM, Wang AM, Koci TM, Tali ET, Fisher DJ, Simon JH, Jinkins JR, Tsai F (1994) Venous sinus occlusive disease: MR findings. AJNR Am J Neuroradiol 15:309–316PubMed
14.
Zurück zum Zitat Huckman MS, Fox JS, Ramsey RG, Penn RD (1976) Computed tomography in the diagnosis of pseudotumor cerebri. Radiology 119:593–597PubMed Huckman MS, Fox JS, Ramsey RG, Penn RD (1976) Computed tomography in the diagnosis of pseudotumor cerebri. Radiology 119:593–597PubMed
15.
Zurück zum Zitat Silbergleit R, Junck L, Gebarski SS, Hatfield MK (1989) Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 170:207–209PubMed Silbergleit R, Junck L, Gebarski SS, Hatfield MK (1989) Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. Radiology 170:207–209PubMed
16.
Zurück zum Zitat Jacobson DM, Karanjia PN, Olson KA, Warner JJ (1990) Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 40:1454–1455PubMed Jacobson DM, Karanjia PN, Olson KA, Warner JJ (1990) Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri. Neurology 40:1454–1455PubMed
17.
Zurück zum Zitat Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F, Henriksen O (1995) Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 16:381–387PubMed Gideon P, Sorensen PS, Thomsen C, Stahlberg F, Gjerris F, Henriksen O (1995) Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 16:381–387PubMed
18.
Zurück zum Zitat Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198–202PubMed Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198–202PubMed
19.
Zurück zum Zitat Johnston I, Kollar C, Dunkley S, Assaad N, Parker G (2002) Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 9:273–278PubMedCrossRef Johnston I, Kollar C, Dunkley S, Assaad N, Parker G (2002) Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 9:273–278PubMedCrossRef
20.
Zurück zum Zitat Lee AG, Brazis PW (2000) Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol 20:12–13PubMed Lee AG, Brazis PW (2000) Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol 20:12–13PubMed
Metadaten
Titel
Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs
verfasst von
R. Agid
R. I. Farb
R. A. Willinsky
D. J. Mikulis
G. Tomlinson
Publikationsdatum
01.08.2006
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 8/2006
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-006-0095-y

Weitere Artikel der Ausgabe 8/2006

Neuroradiology 8/2006 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.